FDA considers a substance to become "approved for investigation as a whole new drug" whether it is the subject of the Investigational New Drug application (IND) which has gone into impact. Below FDA’s restrictions (21 CFR 312.2), Except a medical investigation satisfies the confined standards in that regulation, an IND https://cashqdkpz.bloggactif.com/34306830/thc-no-further-a-mystery